CLSI C49 (R2023)

This guideline provides information for the medical laboratory for evaluating measurement procedures, as well as a strategy to characterize assay performance when applied to body fluid matrixes. Key concepts that apply to the entire test cycle, including preexamination, examination, and postexamination phases of body fluid testing, are discussed.